For following the competition: what moved in each program, several studies read as one move.
- bimagrumab
- MF-300
- CG-BM1- 5.0 × 10^7 cells
- + 8 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Sarcopenia to watchlistEvery Monday by email · turn it off any timePro · free during the beta